Michael Rudnicki

Michael Rudnicki

Net worth: 2 M $ as of 30/05/2026

Health Technology
Commercial Services
Consumer Services

Profile

Michael Rudnicki is the founder of Fate Therapeutics, Inc. (founded in 2007).
Dr. Rudnicki is the founder of Satellos Bioscience, Inc. (founded in 2018) and holds the title of Chief Discovery Officer.
Dr. Rudnicki is also the founder of Verio Therapeutics, Inc. Dr. Rudnicki is the Director-Sprott Centre for Stem Cell Research at Ottawa Hospital Research Institute.
Dr. Rudnicki is the Scientific Director at Stem Cell Network.
Dr. Rudnicki is a Professor at the University of Ottawa.
Dr. Rudnicki was the Director at The Ontario Institute For Regenerative Medicine.
Dr. Rudnicki earned an undergraduate degree and a doctorate from the University of Ottawa.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
01/04/2026 258,159 ( 1.24% ) 2 M $ 30/05/2026

Michael Rudnicki active positions

CompaniesPositionStart
SATELLOS BIOSCIENCE INC. Founder 31/12/2017
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -

Former positions of Michael Rudnicki

CompaniesPositionEnd
Founder -
Director/Board Member -
Founder -
FATE THERAPEUTICS, INC. Founder -
See the detail of Michael Rudnicki's experience

Training of Michael Rudnicki

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

28

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Consumer Services

Health Technology

Health Services

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Michael Rudnicki